Skip to content

Biohaven BHVN Accumulated Depreciation

Accumulated Depreciation at other companies

Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$49.9M+28.4%
ADMA Biologics logo
ADMA BiologicsADMA
$40M+12.7%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$39.72M+8.1%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
Biogen logo
BiogenBIIB
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX

Other financials

Income statement

See full
Operating income-$130.4M+41.1%
Net income-$130.5M+41.1%
EPS (diluted)-$0.88+59.4%

Balance sheet

See full
Cash & equivalents$277.1M+170%
Total debt$286.2M+706%
Total equity$129.5M-50.1%
Total assets$466.4M+1.6%

Cash flow

See full
Operating cash flow-$149.9M+9.2%
CapEx--100%
Free cash flow-$149.9M+9.5%

Valuation

See full
Market cap$2.25B-48.1%

Returns & leverage

See full
Return on equity-333%+17.9pp
Debt / equity2.2×+2.1×
Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's accumulated depreciation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biohaven's accumulated depreciation?
Biohaven (BHVN) reported accumulated depreciation of $16.83M in Q1 2026.
How has Biohaven's accumulated depreciation changed year-over-year?
Biohaven's accumulated depreciation increased by 27.3% year-over-year, from $13.22M to $16.83M.
What is the long-term trend for Biohaven's accumulated depreciation?
Over 4 years (2021 to 2025), Biohaven's accumulated depreciation has grown at a 48.2% compound annual growth rate (CAGR), from $3.34M to $16.13M.
What does accumulated depreciation mean?
Total accumulated depreciation on property, plant, and equipment since acquisition — represents the consumed portion of asset useful lives.